Biowet Drwalewsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-02-10
Share capital
1,000,000.00 PLN
Activity description

Biowet Drwalew produces veterinary products, including chemotherapeutics, calcium preparations, ointments and biological preparations, as well as synbiotics for livestock buildings and products for dogs and cats. The company provides manufacturing and distribution services for the veterinary and livestock sectors.

Registered address
ul. Grójecka 6, 05-651 Drwalew, Poland
Opening hours
Monday–Friday
8:00–16:00
Phone
Electronic delivery address
AE:PL-86218-50838-HRGWF-27

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 78 days early. 5 of 6 audited by a statutory auditor.

  • 202507/05/2026
  • 202412/05/2025
  • 202314/05/2024
  • 202207/06/2023
  • 202120/04/2022
  • 202017/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 12.63mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 256.55kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 12.01mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 5.87mMedianUSD 609.79kAverageUSD 11.85m

Offer

  • Veterinary preparations
  • Synbiotics
  • Products for dogs
  • Products for cats
Certifications: GMP

Website technology

Website
  • WordPress
Analytics and marketing
  • Google Analytics

Public procurement

Biowet Drwalew is the contractor in one public sector contract, worth USD 1.97k.

SubjectAmount
Purchase of consumables required for veterinary ophthalmic surgery
$1,970

Trademarks

Biowet Drwalew holds 45 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 1974.

MarkNumberClassesStatusProtected until
BIOLENT(word)Z.5743473, 5Protected Oct 4, 2034
BIOVAL(word)Z.5737953, 5Protected Aug 28, 2034
BIOXITON(word)Z.5559185Protected May 16, 2033
CUNIBIOVAC(word)Z.5559095Protected May 16, 2033
INMUFORT BOV(word)Z.5559155Protected May 16, 2033
MarkProtected until
BIOLENT(word)Oct 4, 2034
BIOVAL(word)Aug 28, 2034
BIOXITON(word)May 16, 2033
CUNIBIOVAC(word)May 16, 2033
INMUFORT BOV(word)May 16, 2033

Authorized Representatives

Bogusław Wincenty Monczak – President of the Management Board
Maria Jolanta Kędzierska – Attorney-in-fact (joint)

Manner of representation

President of the Management Board independently. In the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy.

Supervisory board

Akinkayode Robert Phillips – Supervisory Board Member
Juan Ovejero Guisasola – Supervisory Board Member
Juan Ovejero Zavagli – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
20,000$270,124.26100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2015-07-16.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $68,875.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$14,623
De minimis aid (in accordance with Commission Regulation 2023/2831)
$2,585
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$13,496

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Dongkwang Polandsp. z o.o.
OwlieS.A.
Vitamed Pharmaceuticalssp. z o.o.
Pharmabestsp. z o.o.
Wega Bissp. z o.o.
Biopoint M.Jankowski M.Niewiadomskasp. j.
Over Groupsp. z o.o. + limited partnership
Panawitsp. z o.o.
BWT Polskasp. z o.o.
Vet-Agro Tradingsp. z o.o.

Change history

DateEvent
2020-07-01Share capital increase
2020-07-01Name change
2020-07-01PKD change
2019-07-04Address change
2019-07-04Share capital increase

FAQ

Last updated: 2026-10-07